Methodological Concerns Regarding the Causal Relationship Between Methotrexate and COPD: The Missing Confounding by Indication [Letter]. [PDF]
Shan Q.
europepmc +1 more source
Feasibility, acceptability, and preliminary impact of a text messaging intervention to increase the uptake of lung cancer screening among Latinos: single-arm pilot study. [PDF]
Ramos-Santiago JW +15 more
europepmc +1 more source
A Real-World Evaluation of Therapeutic Inertia in Patients with Severe Uncontrolled Chronic Obstructive Pulmonary Disease [Letter]. [PDF]
Shan Q.
europepmc +1 more source
Exploring Relevance of Graded Sputum Production in Stable COPD in Clinical Practice. [PDF]
Morin L, Borel JC, Arnol N, Aguilaniu B.
europepmc +1 more source
Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Response to Letter]. [PDF]
Cherian M, Suissa S.
europepmc +1 more source
Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]. [PDF]
Wedzicha JA, Kiran A.
europepmc +1 more source
Construct Validity Matters: Are CAT and 5STS Surrogates of Exercise Capacity in COPD? [Letter]. [PDF]
Vera-Uribe R +2 more
europepmc +1 more source
[Ethical and technical challenges of lung screening in Catalonia]. [PDF]
Villar Pablos A, Lozano A.
europepmc +1 more source
[Anomalous origin of the right pulmonary artery: Non-invasive diagnosis and early surgery]. [PDF]
Serrano-Ramírez VO +2 more
europepmc +1 more source
[Controversies surrounding lung cancer screening]. [PDF]
Moreno-Bartolomé C +2 more
europepmc +1 more source

